# OnCo record mnpr-101 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mnpr-101/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mnpr-101" ;
  schema:name "MNPR-101"@en ;
  schema:description "MNPR-101 is an experimental radiolabelled humanised monoclonal antibody from Monopar Therapeutics, in phase 1 trials for advanced solid tumours expressing uPAR, bladder/urothelial cancer and triple-negative breast cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/mnpr-101/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.monopartx.com>, <https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm>, <https://clinicaltrials.gov/study/NCT06617169>, <https://clinicaltrials.gov/search?intr=MNPR-101> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Radiolabelled humanised monoclonal antibody (imaging with zirconium-89; therapy with lutetium-177, actinium-225 preclinical)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:companies <https://onco.cc/companies/monopar/> ;
  onco:trials <https://onco.cc/trials/nct06337084/>, <https://onco.cc/trials/nct06617169/> .